Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke

Inger de Ridder; Maaike Dirks; Louis Niessen; Diederik Dippel; PRACTISE Investigators

doi:10.1161/STROKEAHA.113.002263

Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke

Inger de Ridder, Maaike Dirks, Louis Niessen, Diederik Dippel, PRACTISE Investigators

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Abstract

A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.

Original language	English
Pages (from-to)	2610-2
Number of pages	3
Journal	Stroke
Volume	44
Issue number	9
DOIs	https://doi.org/10.1161/STROKEAHA.113.002263
Publication status	Published - Sep 2013

Keywords

Administration, Intravenous
Aged
Aged, 80 and over
Brain Ischemia
Clinical Trials as Topic
Female
Fibrinolytic Agents
Health Services Accessibility
Humans
Male
Middle Aged
Severity of Illness Index
Sex Factors
Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
Treatment Outcome

Access to Document

10.1161/STROKEAHA.113.002263

Cite this

@article{bbf6f423d9fe404db9386a2126bb84f7,

title = "Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke",

abstract = "A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.",

keywords = "Administration, Intravenous, Aged, Aged, 80 and over, Brain Ischemia, Clinical Trials as Topic, Female, Fibrinolytic Agents, Health Services Accessibility, Humans, Male, Middle Aged, Severity of Illness Index, Sex Factors, Stroke, Thrombolytic Therapy, Tissue Plasminogen Activator, Treatment Outcome",

author = "{de Ridder}, Inger and Maaike Dirks and Louis Niessen and Diederik Dippel and {PRACTISE Investigators}",

year = "2013",

month = sep,

doi = "10.1161/STROKEAHA.113.002263",

language = "English",

volume = "44",

pages = "2610--2",

journal = "Stroke",

issn = "0039-2499",

publisher = "Lippincott, Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke

AU - de Ridder, Inger

AU - Dirks, Maaike

AU - Niessen, Louis

AU - Dippel, Diederik

AU - PRACTISE Investigators

PY - 2013/9

Y1 - 2013/9

N2 - A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.

AB - A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.

KW - Administration, Intravenous

KW - Aged

KW - Aged, 80 and over

KW - Brain Ischemia

KW - Clinical Trials as Topic

KW - Female

KW - Fibrinolytic Agents

KW - Health Services Accessibility

KW - Humans

KW - Male

KW - Middle Aged

KW - Severity of Illness Index

KW - Sex Factors

KW - Stroke

KW - Thrombolytic Therapy

KW - Tissue Plasminogen Activator

KW - Treatment Outcome

U2 - 10.1161/STROKEAHA.113.002263

DO - 10.1161/STROKEAHA.113.002263

M3 - Article

C2 - 23887843

VL - 44

SP - 2610

EP - 2612

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -